Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 7362
TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191549(US9181279, E9)
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191551(US9181279, E13)
Affinity DataIC50: 8nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191552(US9181279, E16)
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191554(US9181279, E18)
Affinity DataIC50: 11nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191557(US9181279, E23)
Affinity DataIC50: 11.5nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191555(US9181279, E20 | US9181279, E19)
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191561(US9181279, E29)
Affinity DataIC50: 16nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191562(US9181279, E30)
Affinity DataIC50: 21nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191548(US9181279, E7)
Affinity DataIC50: 22nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191555(US9181279, E20 | US9181279, E19)
Affinity DataIC50: 23nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191553(US9181279, E17)
Affinity DataIC50: 28nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191550(US9181279, E10)
Affinity DataIC50: 29nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191547(US9181279, E4)
Affinity DataIC50: 32nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191559(US9181279, E26)
Affinity DataIC50: 42nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191558(US9181279, E25)
Affinity DataIC50: 43nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Rottapharm Biotech

US Patent
LigandPNGBDBM191560(US9181279, E27)
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:The assay is based on the competition between endogenous cAMP and exogenously added biotinylated cAMP. The capture of cAMP is achieved by using a spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2016
Entry Details
Go to US Patent